[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-289437-105":59,"doc-detail-289437-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ich-e6-r3-step-5-guideline-for-good-clinical-practice-gcp","ICH E6 (R3) - Step 5 - Guideline for good clinical practice (GCP)","","ICH E6 (R3) Guideline for good clinical practice (GCP) Step 5 presents regulatory milestones and endorsement history for the ICH GCP guideline, including transmission, adoption, public consultation release, comment deadlines, final adoption, and effective date. It also provides the document’s internal structure through a detailed table of contents covering introduction, ICH GCP principles, and Annex 1 topics such as IRB/IEC, investigator responsibilities, sponsor requirements, trial design, participant safety, records, and reporting.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ich-e6-r3-step-5-guideline-for-good-clinical-practice-gcp/289437/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ich-e6-r3-step-5-guideline-for-good-clinical-practice-gcp/289437.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-17",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are the key regulatory dates for ICH E6 (R3) Step 5?","Question",{"text":113,"@type":114},"The document lists transmission to CHMP, adoption by CHMP, release for public consultation, comment deadline, final adoption by CHMP, and the date for coming into effect.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is covered in Annex 1 of the ICH E6 (R3) guideline?",{"text":118,"@type":114},"Annex 1 includes sections on IRB/IEC, investigator responsibilities and procedures, and sponsor requirements such as trial design, resources, and allocation of activities.",{"name":120,"@type":111,"acceptedAnswer":121},"Which topics are addressed under the investigator section?",{"text":122,"@type":114},"The table of contents shows items including qualifications and training, resources, responsibilities, communication with IRB/IEC, protocol compliance, trial termination or suspension, participant medical care and safety reporting, informed consent, investigational product management, randomization/unblinding, records, and reports.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},289437,1790177136,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":39,"preview_urls":147},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","23 January 2025  \nEMA/CHMP/ICH/135/1995  \nCommittee for Human Medicinal Products  \nICH E6 (R3) Guideline for good clinical practice (GCP)  \nStep 5  \n\n| Transmission to CHMP | 25 May 2023 |\n| --- | --- |\n| Adoption by CHMP | 25 May 2023 |\n| Release for public consultation | 26 May 2023 |\n| Deadline for comments | 26 September 2023 |\n| Final adoption by CHMP | 12 December 2024 |\n| Date for coming into effect | 23 July 2025 |\n\nOfficial address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to [www.ema.europa.eu/how-to-find-us](www.ema.europa.eu/how-to-find-us)  \nSend us a question Go to [www.ema.europa.eu/contact](www.ema.europa.eu/contact) Telephone +31 (0)88 781 6000  \nAn agency of the European Union  \n© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.  \n\n| Code | History | Date |\n| --- | --- | --- |\n| E6 | Approval by the Steering Committee under Step 2 and release for public consultation. | 27 April 1995 |\n| E6 | Approval by the Steering Committee under Step 4 and recommended for adoption to the three ICH regulatory bodies. | 1 May 1996 |\n| E6(R1) | Approval by the Steering Committee of Post-Step 4 editorial corrections. | 10 June 1996 |\n| E6(R2) | Adoption by the Regulatory Members of the ICH Assembly under Step 4. Integrated Addendum to ICHE6(R1) document. Changes are integrated directly into the following sections of the parental Guideline:\u003Cbr>Introduction, 1.63, 1.64, 1.65, 2.10, 2.13, 4.2.5, 4.2.6, 4.9.0, 5.0, 5.0.1, 5.0.2, 5.0.3, 5.0.4, 5.0.5, 5.0.6, 5.0.7, 5.2.2, 5.5.3 (a), 5.5.3 (b), 5.5.3 (h), 5.18.3, 5.18.6 (e), 5.18.7, 5.20.1, 8.1 | 9 November 2016 |\n| E6(R3) | Endorsement by the Members of the ICH Assembly under Step 2 and release for public consultation . | 19 May 2023 |\n| E6(R3) | Endorsement by the Regulatory Members of the ICH Assembly under Step 4. | 06 January 2025 |\n\nICH E6 (R3) Guideline for good clinical practice (GCP)  \nEMA/CHMP/ICH/135/1995EMA/CHMP/ICH/135/1995 Page 2/71  \nGuideline for good clinical practice (GCP) E6(R3)  \nTable of contents  \nI. Introduction ............................................................................................................... 6  \nGuideline scope ................................................................................................................... 6  \nGuideline structure ............................................................................................................... 6  \nII. Principles of ICH GCP .................................................................................................. 7  \nIII. Annex 1 .................................................................................................................... 11  \n1. Institutional Review Board/Independent Ethics Committee (IRB/IEC) .................... 11  \n1.1 Submission and communication ................................................................................... 11  \n1.2 Responsibilities .......................................................................................................... 12  \n1.3 Composition, functions and operations .......................................................................... 13  \n1.4 Procedures ................................................................................................................ 13  \n1.5 Records .................................................................................................................... 14  \n2. Investigator .............................................................................................................. 15  \n2.1 Qualifications and training ........................................................................................... 15  \n2.2 Resources ................................................................................................................. 15  \n2.3 Responsibilities ........................................................................","cbCais8lITcfaXus","https://ap.wps.com/l/cbCais8lITcfaXus","pdf",627241,71,"English","# Introduction\n## Guideline scope\n## Guideline structure\n# Principles of ICH GCP\n# Annex 1\n## Institutional Review Board/Independent Ethics Committee (IRB/IEC)\n## Investigator\n## Sponsor","[{\"question\":\"What are the key regulatory dates for ICH E6 (R3) Step 5?\",\"answer\":\"The document lists transmission to CHMP, adoption by CHMP, release for public consultation, comment deadline, final adoption by CHMP, and the date for coming into effect.\"},{\"question\":\"What is covered in Annex 1 of the ICH E6 (R3) guideline?\",\"answer\":\"Annex 1 includes sections on IRB/IEC, investigator responsibilities and procedures, and sponsor requirements such as trial design, resources, and allocation of activities.\"},{\"question\":\"Which topics are addressed under the investigator section?\",\"answer\":\"The table of contents shows items including qualifications and training, resources, responsibilities, communication with IRB/IEC, protocol compliance, trial termination or suspension, participant medical care and safety reporting, informed consent, investigational product management, randomization/unblinding, records, and reports.\"}]","ICH E6 (R3) - Step 5 - Guideline for good clinical practice (GCP) | PDF",1789635234,179,[148,152,156,160,164,168,172,176],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/4dbee405d2b9340394bb534692cca8a3.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/e4a066ea67badc2d3f6bd7b41253dc36.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/539d2f6dac6726ef6c778fcd51395374.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/09a3f1c2fd12cc227d8034a590d0a59d.webp",980,1268,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/b3455254b2fe5357e20e4441053842f7.webp",979,1267,{"page_no":29,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/e9c29ced024dc5c8e4d75101abce79b0.webp",978,1265,{"page_no":34,"url":173,"width":174,"height":175},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/ad82690375704bbf2f92c05bed7136b9.webp",977,1264,{"page_no":39,"url":177,"width":178,"height":179},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/ef6a100113eb340207161bba6be0297e.webp",976,1263]